NYSE$AMCR
Amcor PLC · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
Reported a solid second quarter result with further sequential improvement in year over year volume growth and margins expansion.
Amcor reported net sales of $3,241 million and GAAP net income of $163 million for the December 2024 quarter. Adjusted EBIT increased by 5% on a comparable constant currency basis, reaching $363 million, and adjusted EPS also grew by 5% to 16.1 cents per share. The company reaffirmed its fiscal year 2025 outlook and announced a combination with Berry Global.
- Further sequential improvement in year over year volume growth.
- Net sales of $3,241 million.
- GAAP Net income of $163 million; GAAP diluted earnings per share (EPS) of 11.3 cps.
- Adjusted EBIT of $363 million, up 5% on a comparable constant currency basis.
Headline financials
Revenue & EPS history
Amcor · Revenue · Quarterly
$3.24B
Revenue by segment
Amcor · $3.44B total across 2 segments · Q1 2024
- Flexible Packaging$2.57B-7.6%74.6%
- Rigid Packaging$875M-6.2%25.4%
Forward guidance
Amcor reaffirmed its fiscal 2025 outlook, expecting adjusted EPS of 72-76 cents per share and adjusted free cash flow of $900-1,000 million.
Tailwinds
- Adjusted EPS of approximately 72 to 76 cents per share, which represents comparable constant currency growth of 3% to 8% compared with 70.2 cents per share in fiscal 2024.
- Movements in exchange rates are not expected to have a material impact on reported EPS.
- Adjusted Free Cash Flow of approximately $900 million to $1,000 million.
- Delivering fourth consecutive quarter of sequential volume improvement.
- Combination with Berry Global to significantly enhance value for our customers and shareholders
Headwinds
- Normalization of incentive compensation payments represents approximately 4% headwind.
- Consumer and customer demand remained soft and variable in the North America beverage business
- Destocking continued in healthcare
- Price/mix had an unfavorable impact of approximately 2% primarily due to lower volumes in high value healthcare categories.
- Volumes were broadly in line with last year in Latin America.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
+6.3%
Avg return
Earnings day
+0.3%
Avg return
5 days after
-1.9%
Avg return
30 days after
37%
21 / 57 earnings
Positive
+356.4%
Q3 2023
Best reaction
-10.9%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -0.7% | -2.7% | -5.2% | |
| Q2 2026 | +8.1% | +7.8% | -3.7% | |
| Q1 2026 | +1.5% | +4.8% | +2.9% | |
| Q3 2025 | +0.0% | -0.2% | -1.0% | |
| Q2 2025 | +0.0% | +4.8% | +5.8% | |
| Q1 2025 | +0.0% | -7.2% | -3.8% | |
| Q4 2024 | -10.9% | +1.2% | +3.1% | |
| Q3 2024 | +0.0% | +10.6% | +9.2% | |
| Q2 2024 | +1.6% | -1.3% | +2.2% | |
| Q1 2024 | -1.7% | +2.8% | +7.0% | |
| Q4 2023 | +1.2% | -0.3% | -1.4% | |
| Q3 2023 | +356.4% | -5.8% | -12.1% | |
| Q2 2023 | -5.5% | -5.0% | -9.1% | |
| Q1 2023 | +0.1% | -3.6% | +6.9% | |
| Q4 2022 | -2.1% | -6.1% | -12.3% | |
| Q3 2022 | +2.3% | +9.5% | +15.0% | |
| Q2 2022 | +1.6% | -3.7% | -5.5% | |
| Q1 2022 | +1.2% | +1.7% | -3.9% | |
| Q4 2021 | -1.0% | +4.7% | -0.7% | |
| Q3 2021 | +0.0% | +5.6% | +1.3% | |
| Q2 2021 | -0.9% | +5.3% | +3.5% | |
| Q1 2021 | +3.8% | +6.9% | +4.1% | |
| Q4 2020 | -2.0% | -1.8% | +0.1% | |
| Q3 2020 | -1.6% | +1.4% | +9.5% | |
| Q2 2019 | -3.8% | -5.6% | -38.0% | |
| Q2 2020 | -3.8% | -5.6% | -38.0% | |
| Q1 2019 | +3.2% | -1.4% | +5.0% | |
| Q1 2020 | +3.2% | -1.4% | +5.0% | |
| Q2 2018 | +2.1% | +0.5% | -2.7% | |
| Q1 2018 | +2.1% | +0.5% | -2.7% | |
| Q3 2018 | +2.1% | +0.5% | -2.7% | |
| Q4 2017 | +2.1% | +0.5% | -2.7% | |
| Q4 2018 | +2.1% | +0.5% | -2.7% | |
| Q4 2019 | -1.4% | -6.6% | -3.2% | |
| Q3 2019 | +0.0% | +0.0% | -4.6% | |
| Q3 2017 | +0.0% | +0.0% | +0.4% | |
| Q2 2017 | +0.0% | +0.0% | +0.0% | |
| Q1 2017 | +0.0% | +0.0% | +0.0% | |
| Q4 2016 | -0.7% | -0.7% | +0.6% | |
| Q3 2016 | +0.0% | — | — | |
| Q2 2016 | +1.3% | — | — | |
| Q1 2016 | +0.0% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | -1.8% | — | — | |
| Q2 2015 | +0.0% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | +2.4% | — | — | |
| Q1 2014 | +1.5% | — | — | |
| Q4 2013 | +0.7% | — | — | |
| Q3 2013 | -2.0% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q4 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro